Recent studies have shown that PD-1/PD-L1 can influence tumor progression as a vital immune checkpoint in the tumor microenvironment, and over-expression of PD-1 and PD-L1 contributes to tumor immune escape 46. Here, CD274 is linked to neoplasm.